Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients

Yoshinao Muro, Kazumitsu Sugiura, Masashi Akiyama

研究成果: Article

36 引用 (Scopus)

抄録

Background. The myositis-specific autoantibodies that characterize certain forms of inflammatory myopathy are useful in diagnosing dermatomyositis (DM) / polymyositis and predicting its prognosis. Autoantibodies to small ubiquitin-like modifier activating enzyme (SAE) have been identified as a DM-marker antibody in European Caucasians. Objective and methods. This study investigates the frequency and clinical characteristics of anti-SAE autoantibodies in Japanese patients with DM. Sera from 110 Japanese patients, including 13 with juvenile DM, were screened for anti-SAE antibodies by enzyme-linked immunosorbent assays. Positive sera were further examined by immunoblotting of the immunoprecipitates. Results. Only two patients (1.8%) were confirmed to have anti-SAE antibodies, and neither of these two patients had amyopathic or juvenile DM. One patient with anti-SAE had DM complicated with pulmonary arterial hypertension, and the other had cancer-associated DM. Both had hallmark cutaneous manifestations of DM. Conclusion. This is the first report of anti-SAE antibodies from an Asian single center cohort. Although Japanese patients with anti-SAE antibodies have a clinical phenotype similar to that of Caucasian patients, their frequency was lower in the Japanese patients than in the previously reported Caucasian patients.

元の言語English
ページ(範囲)279-284
ページ数6
ジャーナルAutoimmunity
46
発行部数4
DOI
出版物ステータスPublished - 01-06-2013

Fingerprint

Dermatomyositis
Ubiquitin
Antibodies
Enzymes
Anti-Idiotypic Antibodies
Autoantibodies
Myositis
Skin Manifestations
Serum
Immunoblotting
Pulmonary Hypertension
Enzyme-Linked Immunosorbent Assay
Phenotype

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

これを引用

@article{18add4421a4a48df84381722fc71afc2,
title = "Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients",
abstract = "Background. The myositis-specific autoantibodies that characterize certain forms of inflammatory myopathy are useful in diagnosing dermatomyositis (DM) / polymyositis and predicting its prognosis. Autoantibodies to small ubiquitin-like modifier activating enzyme (SAE) have been identified as a DM-marker antibody in European Caucasians. Objective and methods. This study investigates the frequency and clinical characteristics of anti-SAE autoantibodies in Japanese patients with DM. Sera from 110 Japanese patients, including 13 with juvenile DM, were screened for anti-SAE antibodies by enzyme-linked immunosorbent assays. Positive sera were further examined by immunoblotting of the immunoprecipitates. Results. Only two patients (1.8{\%}) were confirmed to have anti-SAE antibodies, and neither of these two patients had amyopathic or juvenile DM. One patient with anti-SAE had DM complicated with pulmonary arterial hypertension, and the other had cancer-associated DM. Both had hallmark cutaneous manifestations of DM. Conclusion. This is the first report of anti-SAE antibodies from an Asian single center cohort. Although Japanese patients with anti-SAE antibodies have a clinical phenotype similar to that of Caucasian patients, their frequency was lower in the Japanese patients than in the previously reported Caucasian patients.",
author = "Yoshinao Muro and Kazumitsu Sugiura and Masashi Akiyama",
year = "2013",
month = "6",
day = "1",
doi = "10.3109/08916934.2012.755958",
language = "English",
volume = "46",
pages = "279--284",
journal = "Autoimmunity",
issn = "0891-6934",
publisher = "Informa Healthcare",
number = "4",

}

Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients. / Muro, Yoshinao; Sugiura, Kazumitsu; Akiyama, Masashi.

:: Autoimmunity, 巻 46, 番号 4, 01.06.2013, p. 279-284.

研究成果: Article

TY - JOUR

T1 - Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients

AU - Muro, Yoshinao

AU - Sugiura, Kazumitsu

AU - Akiyama, Masashi

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Background. The myositis-specific autoantibodies that characterize certain forms of inflammatory myopathy are useful in diagnosing dermatomyositis (DM) / polymyositis and predicting its prognosis. Autoantibodies to small ubiquitin-like modifier activating enzyme (SAE) have been identified as a DM-marker antibody in European Caucasians. Objective and methods. This study investigates the frequency and clinical characteristics of anti-SAE autoantibodies in Japanese patients with DM. Sera from 110 Japanese patients, including 13 with juvenile DM, were screened for anti-SAE antibodies by enzyme-linked immunosorbent assays. Positive sera were further examined by immunoblotting of the immunoprecipitates. Results. Only two patients (1.8%) were confirmed to have anti-SAE antibodies, and neither of these two patients had amyopathic or juvenile DM. One patient with anti-SAE had DM complicated with pulmonary arterial hypertension, and the other had cancer-associated DM. Both had hallmark cutaneous manifestations of DM. Conclusion. This is the first report of anti-SAE antibodies from an Asian single center cohort. Although Japanese patients with anti-SAE antibodies have a clinical phenotype similar to that of Caucasian patients, their frequency was lower in the Japanese patients than in the previously reported Caucasian patients.

AB - Background. The myositis-specific autoantibodies that characterize certain forms of inflammatory myopathy are useful in diagnosing dermatomyositis (DM) / polymyositis and predicting its prognosis. Autoantibodies to small ubiquitin-like modifier activating enzyme (SAE) have been identified as a DM-marker antibody in European Caucasians. Objective and methods. This study investigates the frequency and clinical characteristics of anti-SAE autoantibodies in Japanese patients with DM. Sera from 110 Japanese patients, including 13 with juvenile DM, were screened for anti-SAE antibodies by enzyme-linked immunosorbent assays. Positive sera were further examined by immunoblotting of the immunoprecipitates. Results. Only two patients (1.8%) were confirmed to have anti-SAE antibodies, and neither of these two patients had amyopathic or juvenile DM. One patient with anti-SAE had DM complicated with pulmonary arterial hypertension, and the other had cancer-associated DM. Both had hallmark cutaneous manifestations of DM. Conclusion. This is the first report of anti-SAE antibodies from an Asian single center cohort. Although Japanese patients with anti-SAE antibodies have a clinical phenotype similar to that of Caucasian patients, their frequency was lower in the Japanese patients than in the previously reported Caucasian patients.

UR - http://www.scopus.com/inward/record.url?scp=84877741907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877741907&partnerID=8YFLogxK

U2 - 10.3109/08916934.2012.755958

DO - 10.3109/08916934.2012.755958

M3 - Article

C2 - 23215730

AN - SCOPUS:84877741907

VL - 46

SP - 279

EP - 284

JO - Autoimmunity

JF - Autoimmunity

SN - 0891-6934

IS - 4

ER -